“[Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis in Italy]”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 18, no. 1S, Apr. 2017, https://doi.org/10.7175/fe.v18i1S.1300.